155 related articles for article (PubMed ID: 33442416)
1. Decision-making of adjuvant therapy in pT1N1M0 gastric cancer: Should radiotherapy be added to chemotherapy? A propensity score-matched analysis.
Pan S; Yin S; Zhu Z; Liu F; Xu H
J Cancer; 2021; 12(4):1179-1189. PubMed ID: 33442416
[No Abstract] [Full Text] [Related]
2. Distinguish the Role of Radiotherapy From Chemoradiotherapy for Gastric Cancer With Behavior of Metastasis-Indolent in Lymph Node.
Zhi Y; Lin Z; Ma J; Mou W; Chen X
Technol Cancer Res Treat; 2020; 19():1533033820959400. PubMed ID: 33148125
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes of neoadjuvant and adjuvant chemoradiotherapy for locally advanced adenocarcinoma of the oesophagogastric junction: a retrospective cohort study using the SEER database.
Zhang F; Feng X; Li Y; Yan J; Zhang Z; Song X
J Gastrointest Oncol; 2022 Feb; 13(1):26-39. PubMed ID: 35284136
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Nomogram for Early Gastric Cancer After Surgery to Assist Decision-Making for Treatment With Adjuvant Chemotherapy.
Zhang C; Zhao S; Wang X
Front Pharmacol; 2022; 13():845313. PubMed ID: 35462895
[No Abstract] [Full Text] [Related]
6. Indications for adjuvant chemotherapy in patients with pT1N1M0 gastric cancer: a single-center experience.
Jin P; Ji X; Ma S; Kang W; Liu H; Li Y; Ma F; Hu H; Li W; Tian Y
J Cancer Res Clin Oncol; 2021 Feb; 147(2):561-568. PubMed ID: 32772233
[TBL] [Abstract][Full Text] [Related]
7. Survival benefits of palliative gastrectomy in stage IV gastric cancer: a propensity score matched analysis.
Peng W; Ma T; Xu H; Wu Z; Wu C; Sun G
J Gastrointest Oncol; 2020 Apr; 11(2):376-385. PubMed ID: 32399278
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
[TBL] [Abstract][Full Text] [Related]
9. The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care.
Boothe D; Williams N; Odei B; Poppe MM; Werner TL; Suneja G; Gaffney DK
Int J Gynecol Cancer; 2017 Jun; 27(5):912-922. PubMed ID: 28498257
[TBL] [Abstract][Full Text] [Related]
10. Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.
Wang Y; Zhang J; Guo S; Dong Z; Meng X; Zheng G; Yang D; Zheng Z; Zhao Y
Clin Transl Oncol; 2019 Nov; 21(11):1499-1509. PubMed ID: 30903518
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival.
Boothe D; Orton A; Odei B; Stoddard G; Suneja G; Poppe MM; Werner TL; Gaffney DK
Gynecol Oncol; 2016 Jun; 141(3):421-427. PubMed ID: 27005441
[TBL] [Abstract][Full Text] [Related]
12. Comparable rates of lymph node metastasis and survival between diffuse type and intestinal type early gastric cancer patients: a large population-based study.
Li ZY; Zhang QW; Teng LM; Zhang CH; Huang Y
Gastrointest Endosc; 2019 Jul; 90(1):84-95.e10. PubMed ID: 30885598
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival.
Odei B; Boothe D; Suneja G; Werner TL; Gaffney DK
Am J Clin Oncol; 2018 Aug; 41(8):784-791. PubMed ID: 28121642
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis.
Wang X; Yin C; Su S; Li X; Wang C; Zhang C; Liu M
BMC Cancer; 2018 Nov; 18(1):1067. PubMed ID: 30400782
[TBL] [Abstract][Full Text] [Related]
15. Differential prognostic implications of gastric adenocarcinoma based on Lauren's classification: a Surveillance, Epidemiology, and End Results (SEER)-based cohort study.
Tang D; Ni M; Zhu H; Cao J; Zhou L; Shen S; Peng C; Lv Y; Xu G; Wang L; Zou X
Ann Transl Med; 2021 Apr; 9(8):646. PubMed ID: 33987344
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
Lin H; Li X; Liu Y; Hu Y
ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
[TBL] [Abstract][Full Text] [Related]
17. The Effectiveness of Gastrectomy With Chemoradiotherapy Among Stage IV Gastric Adenocarcinoma: A Population-Based Analysis.
Li S; Zang L
Front Oncol; 2020; 10():630. PubMed ID: 32411605
[No Abstract] [Full Text] [Related]
18. Survival benefits of palliative gastrectomy for gastric cancer patients with liver metastasis: a population-based propensity score-matched cohort analysis.
Ren B; Yang Y; Lv Y; Liu K
Front Oncol; 2023; 13():1309699. PubMed ID: 38107061
[TBL] [Abstract][Full Text] [Related]
19. Survival benefits of gastrectomy in gastric cancer patients with stage IV: a population-based study.
He X; Lai S; Su T; Liu Y; Ding Y; Quan S; Si J; Sun L
Oncotarget; 2017 Dec; 8(63):106577-106586. PubMed ID: 29290972
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit of surgical resection for stage IV gastric cancer: A SEER-based propensity score-matched analysis.
Sun J; Nan Q
Front Surg; 2022; 9():927030. PubMed ID: 36386506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
